TNXP logo

TNXP

Tonix Pharmaceuticals Holding Corp.

$24.16
-$0.60(-2.42%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
$227.91M
Volume
859.66K
52W Range
$6.76 - $130.00
Target Price
$69.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$53.0K--------------$7.8M$10.1M
Total Revenue
$53.0K--------------$7.8M$10.1M
COST OF GOODS SOLD
Cost of Revenue
----------------$4.7M$7.8M
GROSS PROFIT
Gross Profit
$53.0K--------------$3.0M$2.3M
OPERATING EXPENSES
Operating Expenses
$48.2M$39.0M$21.3M$26.3M$28.8M$50.5M$92.3M$112.1M$121.4M$80.1M
Research & Development
$35.5M$28.5M$13.3M$17.6M$18.2M$36.2M$68.8M$81.9M$86.7M$40.0M
Research Expense
$35.5M$28.5M$13.3M$17.6M$18.2M$36.2M$68.8M$81.9M$86.7M$40.0M
Selling, General & Administrative
$12.7M$10.4M$7.9M$8.8M$10.6M$14.4M$23.5M$30.2M$34.8M$40.1M
Selling & Marketing Expenses
--------------$30.2M$34.8M$40.1M
General & Administrative Expenses
$12.7M$10.4M$7.9M$8.8M$10.6M$14.4M$23.5M$30.2M----
Salaries & Wages
$-4.4M$-3.3M$-1.8M$-1.6M$-1.5M----------
Depreciation & Amortization
$-161.0K$-206.0K$-64.0K$-54.0K$-26.0K$27.0K$50.0K$1.3M$4.3M$3.4M
Amortization
----------------$477.0K$476.0K
Other Operating Expenses
----------$500.0K$600.0K$600.0K$600.0K$300.0K
OPERATING INCOME
Operating income
$-48.2M$-39.0M$-21.3M$-26.3M$-28.8M$-50.5M$-92.3M$-112.1M$-118.4M$-136.7M
EBITDA
$-47.9M$-38.6M$-21.1M$-26.0M$-28.6M$-50.5M$-92.3M$-110.8M$-112.4M$-125.8M
NON-OPERATING ITEMS
Intinc
$108.0K$127.0K$168.0K$233.0K$210.0K$48.0K$25.0K$1.9M$1.7M--
Net Non-Operating Interest Income/Expense
$108.0K$127.0K$168.0K$233.0K$210.0K$48.0K$25.0K$1.9M$1.7M--
Gain on Sale of Securities
------------------$6.2M
Other Income/Expense
--$61.0K----------$1.9M$-1.7M$-4.1M
Other Special Charges
--$72.0K------------$1.7M$-2.1M
SPECIAL ITEMS
Special Income Charges
------------------$59.0M
Impairment of Capital Assets
------------------$59.0M
PRE-TAX INCOME
EBIT
$-48.1M$-38.8M$-21.1M$-26.1M$-28.6M$-50.5M$-92.3M$-112.1M$-116.7M$-130.0M
Pre-Tax Income
$-48.1M$-38.8M$-21.1M$-26.1M$-28.6M$-50.5M$-92.3M$-110.2M$-116.7M$-130.0M
NET INCOME
Net Income
$-48.1M$-38.8M$-21.1M$-26.1M$-28.6M$-50.5M$-92.3M$-110.2M$-116.7M$-130.0M
Net Income (Continuing Operations)
$-48.1M$-38.8M$-21.1M$-26.1M$-28.6M$-50.5M$-92.3M$-110.2M$-116.7M$-130.0M
Net Income (Discontinued Operations)
$-48.1M$-38.8M$-21.1M$-26.1M$-28.6M$-50.5M$-92.3M$-110.2M$-116.7M$-130.0M
Net Income (Common Stockholders)
$-48.1M$-38.8M$-21.1M$-29.4M$-31.1M$-52.2M$-92.3M$-116.9M$-116.7M$-130.0M
Normalized Income
------------------$-23.5M
TOTALS
Total Expenses
$48.2M$39.0M$21.3M$26.3M$28.8M$50.5M$92.3M$112.1M$126.1M$87.8M
SHARE & EPS DATA
Average Shares Outstanding
--------$2$147$562$1.8K$5.3K$736.3K
Average Shares Outstanding (Diluted)
--------$2$147$562$1.8K$5.3K$736.3K
Shares Outstanding
--------$77$506$834$3.1K$26.4K$6.4M
Basic EPS
----$-202.9M$-171.6M$-12.4M$-352.0K$-166.4K$-65.4K$-21.9K$-176.6
Basic EPS (Continuing Operations)
$-1.8B$-986.2M$-202.9M$-171.6M$-12.4M$-352.0K$-166.4K$-65.4K$-21.9K$-176.6
Diluted EPS
----$-202.9M$-171.6M$-12.4M$-352.0K$-166.4K$-65.4K$-21.9K$-176.6
Diluted EPS (Continuing Operations)
--------------$-65.4K$-21.9K$-176.6
OTHER METRICS
Accrued Preferred Stock Dividends
------$3.3M$2.5M$1.3M--$6.7M----
Gain On Sale Of P P E
--$-133.0K----------------
Other Gand A
$12.7M$10.4M$7.9M$8.8M$10.6M$14.4M$23.5M$30.2M----
Other Impairment Of Capital Assets
------------------$48.8M
Other Taxes
----------$-2.2M$-15.3M$-9.5M$-14.5M$-17.4M
Otherunder Preferred Stock Dividend
------$3.3M$2.5M$1.3M--$6.7M----
Preferred Stock Dividends
------$3.3M$2.5M$1.3M--$6.7M----
Rent And Landing Fees
$-6.0M$-700.0K$-600.0K$-500.0K------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2TNXP$24.16-2.4%859.66K
3
4
5
6

Get Tonix Pharmaceuticals Holding Corp. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.